Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1575 of 1631 entries
View as:

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

Phase: N/A Priority: Normal
NCT ID: NCT02784717 Org: User:
Start: 05/11/16 End: 09/24/19 Due: 09/24/20

Study of Copanlisib in Hepatic or Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03172884 Org: User:
Start: 06/14/17 End: 05/15/20 Due: 05/15/21

BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment) and BENEFIT Follow-up Study

Phase: N/A Priority: Normal
NCT ID: NCT00185211 Org: User:
Start: 08/31/02 End: 05/31/08 Due: 05/31/09

COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-i Treatment Due to couGH in Slovakia

Phase: N/A Priority: Normal
NCT ID: NCT01217879 Org: User:
Start: 01/31/10 End: 09/30/10 Due: 09/30/11

Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT01271712 Org: User:
Start: 01/04/11 End: 04/15/19 Due: 04/15/20

Single Dose Study in Subjects With Severe Hemophilia A Comparing Pharmacokinetic Parameters for BAY81-8973 and Advate

Phase: N/A Priority: Normal
NCT ID: NCT02483208 Org: User:
Start: 06/30/15 End: 12/31/15 Due: 12/31/16

Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT04471337 Org: User:
Start: 08/12/20 End: 05/06/21 Due: 05/06/22

Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough

Phase: N/A Priority: Normal
NCT ID: NCT04562155 Org: User:
Start: 10/02/20 End: 07/23/21 Due: 07/23/22

Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization

Phase: N/A Priority: Normal
NCT ID: NCT03127722 Org: User:
Start: 05/03/17 End: 12/31/24 Due: 12/31/25

Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT03573336 Org: User:
Start: 07/04/18 End: 11/26/20 Due: 11/26/21

Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

Phase: N/A Priority: Normal
NCT ID: NCT00356447 Org: User:
Start: 05/31/06 End: 10/31/07 Due: 10/31/08

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05254002 Org: User:
Start: 06/23/22 End: 03/14/25 Due: 03/14/26

Roniciclib Mass Balance Study

Phase: N/A Priority: Normal
NCT ID: NCT02390154 Org: User:
Start: 04/30/15 End: 06/30/16 Due: 06/30/17

Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 10 mg in Japanese Healthy Male Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04511611 Org: User:
Start: 01/24/19 End: 05/13/19 Due: 05/13/20

A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150

Phase: N/A Priority: Normal
NCT ID: NCT01625390 Org: User:
Start: 06/30/12 End: 03/31/14 Due: 03/31/15

A Study to Learn How Well Nifurtimox Works and How Safe it is in Children Aged 0 to 17 Years With Chagas' Disease, an Inflammatory, Infectious Disease Caused by the Parasite Trypanosoma Cruzi

Phase: N/A Priority: Normal
NCT ID: NCT02625974 Org: User:
Start: 01/27/16 End: 08/10/21 Due: 08/10/22

Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and Yasmin + Levomefolate Calcium (Metafolin)

Phase: N/A Priority: Normal
NCT ID: NCT01253174 Org: User:
Start: 08/31/06 End: 07/31/07 Due: 07/31/08

Mirena Efficiency and Tolerability During the First Year of Use

Phase: N/A Priority: Normal
NCT ID: NCT00696202 Org: User:
Start: 09/30/03 End: 03/31/05 Due: 03/31/06

Survey on Menstrual Symptoms, Health Related Quality of Life and Work Productivity in Patients Suffering From Pain During Menstruation (Dysmenorrhea) in Japan

Phase: N/A Priority: Normal
NCT ID: NCT04607382 Org: User:
Start: 09/23/20 End: 06/30/21 Due: 06/30/22

A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children

Phase: N/A Priority: Normal
NCT ID: NCT00468819 Org: User:
Start: 05/31/07 End: 04/30/08 Due: 04/30/09

A Study to Learn More About Using Dienogest to Treat Endometriosis in Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT04495855 Org: User:
Start: 10/28/20 End: 12/23/22 Due: 12/23/23

DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users.

Phase: N/A Priority: Normal
NCT ID: NCT01731132 Org: User:
Start: 07/31/12 End: 07/31/14 Due: 07/31/15

Effectiveness and Tolerability of Long-Acting Nifedipine Gastrointestinal Therapeutic System in Chronic Kidney Disease With Uncontrolled Hypertension Patients, a Prospective, Multicenter, Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT03194633 Org: User:
Start: 07/10/17 End: 08/28/20 Due: 08/28/21

Depression Related Improvement With Vardenafil for Erectile Response

Phase: N/A Priority: Normal
NCT ID: NCT00661219 Org: User:
Start: 12/31/02 End: 11/30/03 Due: 11/30/04

Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)

Phase: N/A Priority: Normal
NCT ID: NCT01523418 Org: User:
Start: 10/31/14 End: 11/30/16 Due: 11/30/17